Craft
  • Home
  •  / TransMedics
TransMedics

TransMedics

Revenue

$30.3 M

FY, 2021

Market Capitalization

$1.4 B

2022-09-19

TransMedics Summary

Company summary

Overview
TransMedics is a medical device company. It develops organ transplant technologies. The Company provides a warm blood perfusion system that allows for a living organ transplant.
Type
Public
Founded
1998
HQ
Andover, MA, US | view all locations
Website
https://www.transmedics.com/
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Waleed Hassanein

    Waleed Hassanein, President and CEO

  • Stephen Gordon

    Stephen Gordon, Chief Financial Officer

  • John Carey

    John Carey, Vice President of Operations

  • Miriam Provost

    Miriam Provost, Vice President of Global Regulatory Affairs

LocationsView all

1 location detected

  • Andover, MA HQ

    United States

    200 Minuteman Rd

TransMedics Financials

Summary financials

Revenue (Q2, 2022)
$20.5M
Gross profit (Q2, 2022)
$14.4M
Net income (Q2, 2022)
($11.5M)
Cash (Q2, 2022)
$30.4M
EBIT (Q2, 2022)
($9.7M)
Enterprise value
$1.4B

Footer menu